Literature DB >> 3457697

Subclinical eating disorders and glycemic control in adolescents with type I diabetes.

R R Wing, M P Nowalk, M D Marcus, R Koeske, D Finegold.   

Abstract

Several recent case reports have shown that anorexia nervosa and bulimia negatively affect glycemic control in diabetic patients. However, there have been no systematic studies to assess the prevalence of clinical or subclinical eating disorders among diabetic patients or to determine the impact of such disturbances on glycemic control. This study reports a survey of 202 adolescents, aged 12-18 yr, seen in the Diabetes Clinic, Children's Hospital of Pittsburgh, who were asked to complete the Binge Eating Scale (BES) and the EAT-26 questionnaire. Responses of diabetic patients to the EAT-26 questionnaire were compared with those of a nondiabetic control group and were related to measures of glycemic control. Diabetic subjects scored higher on the total EAT-26 than nondiabetic control subjects, ordinarily indicative of more eating pathology. However, diabetic subjects scored higher only on the dieting subscale of this questionnaire, probably reflecting adherence to the diabetes dietary regimen. Subjects with diabetes scored lower, or did not differ significantly, from nondiabetic control subjects on measures of oral control and bulimia. Among diabetic subjects, self-reported bulimic behaviors were related to poorer glycemic control. Patients with the highest scores on the BES had an average HbA1 of 13.1% compared with 11.8% for age- and sex-matched patients at the 50th percentile, and 10.8% for patients in the lowest 10th percentile. Further studies are needed to determine whether modification of these eating behaviors would improve glycemic control.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3457697     DOI: 10.2337/diacare.9.2.162

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

Review 1.  The eating attitudes test: twenty-five years later.

Authors:  P E Garfinkel; A Newman
Journal:  Eat Weight Disord       Date:  2001-03       Impact factor: 4.652

2.  The Diabetes Health Profile (DHP): a new instrument for assessing the psychosocial profile of insulin requiring patients--development and psychometric evaluation.

Authors:  K Meadows; N Steen; E McColl; M Eccles; C Shiels; J Hewison; A Hutchinson
Journal:  Qual Life Res       Date:  1996-04       Impact factor: 4.147

3.  Depression in Diabetic Patients: What Is the Link With Eating Disorders? Results of a Study in a Representative Sample of Patients With Type 1 Diabetes.

Authors:  Federica Pinna; Federico Suprani; Valeria Deiana; Lorena Lai; Mirko Manchia; Pasquale Paribello; Giulia Somaini; Enrica Diana; Eraldo Francesco Nicotra; Fernando Farci; Mariangela Ghiani; Rossella Cau; Marta Tuveri; Efisio Cossu; Elena Loy; Andrea Crapanzano; Paola Grassi; Andrea Loviselli; Fernanda Velluzzi; Bernardo Carpiniello
Journal:  Front Psychiatry       Date:  2022-06-16       Impact factor: 5.435

4.  Eating disorders in young adults with insulin dependent diabetes mellitus: a controlled study.

Authors:  C G Fairburn; R C Peveler; B Davies; J I Mann; R A Mayou
Journal:  BMJ       Date:  1991-07-06

Review 5.  Chronic illness and disordered eating: a discussion of the literature.

Authors:  Virginia M Quick; Carol Byrd-Bredbenner; Dianne Neumark-Sztainer
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

6.  Eating and emotional disorders in adolescent obese girls with insulin-dependent diabetes mellitus.

Authors:  G Vila; J J Robert; C Nollet-Clemencon; L Vera; H Crosnier; G Rault; J Jos; M C Mouren-Simeoni
Journal:  Eur Child Adolesc Psychiatry       Date:  1995-10       Impact factor: 4.785

7.  Obese Patients With a Binge Eating Disorder Have an Unfavorable Metabolic and Inflammatory Profile.

Authors:  Elena Succurro; Cristina Segura-Garcia; Mariafrancesca Ruffo; Mariarita Caroleo; Marianna Rania; Matteo Aloi; Pasquale De Fazio; Giorgio Sesti; Franco Arturi
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.